SCHEMBL7679791

SCHEMBL7679791

COc1cc(N)c(N)c(OC)c1-c1ccc(N)c(N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP3A4 P08684 2/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TERT O14746 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MGAM O43451 3/20 0.38
GAA P10253 3/20 0.38
SI P14410 3/20 0.38
MGAM2 Q2M2H8 3/20 0.38
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679792 0.73 TDP1 (0.47) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL2905402 0.72 POLB (0.53) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL29655073 0.70 MGAM (0.48) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL32670765 0.68 IDO1 (0.48) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL9455828 0.68 IDO1 (0.48) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL29655234 0.67 PTPRC (0.56) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL5953394 0.67 PTPRC (0.56) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL22206776 0.67 ALDH1A1 (0.67) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL209984 0.66 NPC1 (0.56) ALDH1A1TDP1CYP3A4TSHRHSD17B10
SCHEMBL29532421 0.66 NPC1 (0.56) ALDH1A1TDP1CYP3A4TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6441198-B1 USEFUL AS ANTITUMOUR AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-08-27 US claimed
US-20020082432-A1 New podophyllotoxin dimer as DNA topoisomerase II inhibitors, and a process for the preparation therefore COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2002-06-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020082432-A1 New podophyllotoxin dimer as DNA topoisomerase II inhibitors, and a process for the preparation therefore TOP2A, TOP2B, PCNA ALDH1A1 3688/4885TDP1 65/4885CYP3A4 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.